Tag: ASCO

2 6/7/2017

CAR T-cell therapy — Why it’s too soon to speculate about a ‘cure’ for multiple myeloma

1 6/6/2017

High drug costs (and stock values) take center stage at final day of ASCO

6/5/2017

Small studies get big headlines at ASCO 2017

1 6/6/2016

Readers drowning in flawed “liquid biopsy” stories; other coverage throws a lifeline

5/31/2016

Stanford group offers prize for healthcare social media research ideas

5/17/2013

Here we go again: early news on early abstract release from ASCO

Blog

Opinions on other issues in news, journals, PR, advertising, marketing

View More

Categories

View More

Tags

@HealthNewsRevu

Retweet on TwitterHealthNewsReview.org Retweeted
juadamsJill U Adams@juadams·

One sentence from an @npr story about #opioids prompted twitter rage amongst #addiction specialists. I took a closer look at the issue - an insurance barrier called prior authorization - for @HealthNewsRevu. @jonathan_giftos @LarochelleMarc @maiasz https://t.co/QgL8K8zJUD

Reply on TwitterRetweet on Twitter2Like on Twitter1Twitter
HealthNewsRevuHealthNewsReview.org@HealthNewsRevu·

Smartphone device’s early lab results no substitute for real-world infectious disease detection https://t.co/0d6MuHekD9

Reply on TwitterRetweet on Twitter1Like on TwitterTwitter
HealthNewsRevuHealthNewsReview.org@HealthNewsRevu·

Insurance company red tape: a potentially deadly barrier to opioid addiction treatment. By @juadams
https://t.co/pxQIEkPeuu

Reply on TwitterRetweet on TwitterLike on Twitter1Twitter